Vedolizumab,Ustekinumab,Risankizumab
Takeda,Janssen,Abbvie,Boehringer Ingelheim
. &amp; awesome debate! continue on vdz w/dose escalation or not? suggests moving forward with ust or risa especially to address eims. considering adding mtx for short-term to get joints better controlled. #cccongress23 
Multi Award-Winning #IBD & #FGID Patient Advocate • Team @southasianibd & @ibdesis • MPH ‘23 @IcahnMountSinai • She/Her